1.
Devolder MEC, Pereira ST, Pinto RFM, Dourado PAL, Rocha DRB, Gomes DHS, et al. CLINICAL OUTCOMES OF LONG-TERM USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE. REASE [Internet]. 2024 Aug. 19 [cited 2026 Oct. 6];10(8):2042-5. Available from: https://periodicorease.pro.br/rease/article/view/15327